Manufacturers Convert Production Toward Clinical-Grade Printing
Large multi-brand and cochlear-implant operators have increasingly prioritized converting standard shell-only orders toward documented clinical-grade digital-printing architectures rather than relying on shell-only deployment across critical audiology programs, treating biocompatibility transparency as a defining qualification consideration rather than a secondary specification handled after core fit coverage. Several major manufacturers now require multi-year fit-validation documentation before finalizing new production-vendor partnerships, rather than accepting shell-format qualification common across earlier procurement cycles. Formlabs has invested heavily in dedicated clinical-grade infrastructure, recognizing that large manufacturer mandates hinge on biocompatibility depth over unit price terms alone. That investment pace continues accelerating nationwide.
Market Impact: Aging population growth adds 11%
